HBV | Annotated Bibliography
The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of annotations deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
1. Safety, Tolerability And Antiviral Activity Of The Antisense Oligonucleotide Bepirovirsen In Patients With Chronic Hepatitis B: A Phase 2 Randomized Controlled Trial
Nat Med. 2021 Oct;27(10):1725-1734. doi: 10.1038/s41591-021-01513-4.Epub 2021 Oct 12.
Man-Fung Yuen 1 , Jeong Heo 2 , Jeong-Won Jang 3 , Jung-Hwan Yoon 4 , Young-Oh Kweon 5 , Sung-Jae Park 6 , Yvonne Tami 7 , Shihyun You 8 , Phillip Yates 9 , Yu Tao 8 , Jennifer Cremer 10 , Fiona Campbell 9 , Robert Elston 9 , Dickens Theodore 10 , Melanie Paff 8 , C Frank Bennett 7 , T Jesse Kwoh 7
4. Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B
Lok AS1, Zoulim F2, Dusheiko G3, Chan HLY4, Buti M5, Ghany MG6, Gaggar A7, Yang JC7, Wu G7, Flaherty JF7, Subramanian GM7, Locarnini S8, Marcellin P9. Hepatol Commun. 2019 Oct 10;4(1):8-20. doi: 10.1002/hep4.1436. eCollection 2020 Jan.
Follow us